SBRT is a reasonable treatment modality for early-stage NSCLC in older adults. It achieved good survival outcomes and low toxicity. The proposed nomogram may be able to estimate individual outcomes for these patients.
Keyphrases
- early stage
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- small cell lung cancer
- radiation therapy
- prognostic factors
- oxidative stress
- type diabetes
- physical activity
- squamous cell carcinoma
- lymph node metastasis
- adipose tissue
- insulin resistance
- smoking cessation
- replacement therapy